BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32580932)

  • 21. Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking.
    Vetreno RP; Qin L; Crews FT
    Neurobiol Dis; 2013 Nov; 59():52-62. PubMed ID: 23867237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE Receptors.
    Li W; Zhu S; Li J; D'Amore J; D'Angelo J; Yang H; Wang P; Tracey KJ; Wang H
    Mol Med; 2015 Jun; 21(1):515-25. PubMed ID: 26052716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
    Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
    J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. n-3 polyunsaturated fatty acids alleviate the progression of obesity-related osteoarthritis and protect cartilage through inhibiting the HMGB1-RAGE/TLR4 signaling pathway.
    Xiong T; Huang S; Wang X; Shi Y; He J; Yuan Y; Wang R; Gu H; Liu L
    Int Immunopharmacol; 2024 Feb; 128():111498. PubMed ID: 38218011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
    Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q
    J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycyrrhizin regulates rat TMJOA progression by inhibiting the HMGB1-RAGE/TLR4-NF-κB/AKT pathway.
    Hu Z; Xiao M; Cai H; Li W; Fang W; Long X
    J Cell Mol Med; 2022 Feb; 26(3):925-936. PubMed ID: 34953035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
    Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Nomoto M; Miyashita S; Suzuki K; Nakamura M; Watanabe K
    Exp Dermatol; 2015 Jun; 24(6):418-23. PubMed ID: 25739980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.
    Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K
    Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway.
    Shang D; Peng T; Gou S; Li Y; Wu H; Wang C; Yang Z
    Sci Rep; 2016 Aug; 6():32180. PubMed ID: 27572515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.
    Stark K; Philippi V; Stockhausen S; Busse J; Antonelli A; Miller M; Schubert I; Hoseinpour P; Chandraratne S; von Brühl ML; Gaertner F; Lorenz M; Agresti A; Coletti R; Antoine DJ; Heermann R; Jung K; Reese S; Laitinen I; Schwaiger M; Walch A; Sperandio M; Nawroth PP; Reinhardt C; Jäckel S; Bianchi ME; Massberg S
    Blood; 2016 Nov; 128(20):2435-2449. PubMed ID: 27574188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGB1 and RAGE in inflammation and cancer.
    Sims GP; Rowe DC; Rietdijk ST; Herbst R; Coyle AJ
    Annu Rev Immunol; 2010; 28():367-88. PubMed ID: 20192808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway.
    Zhang L; Yang X; Jiang G; Yu Y; Wu J; Su Y; Sun A; Zou Y; Jiang H; Ge J
    Int J Mol Med; 2019 Sep; 44(3):885-892. PubMed ID: 31524228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
    Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
    Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.
    Yang H; Wang H; Chavan SS; Andersson U
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S6-S12. PubMed ID: 26605648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
    Park JS; Svetkauskaite D; He Q; Kim JY; Strassheim D; Ishizaka A; Abraham E
    J Biol Chem; 2004 Feb; 279(9):7370-7. PubMed ID: 14660645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats.
    Zhang H; Zhang R; Chen J; Shi M; Li W; Zhang X
    Kidney Blood Press Res; 2017; 42(5):894-904. PubMed ID: 29241180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
    Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HMGB1/RAGE Pro-Inflammatory Axis in the Human Placenta: Modulating Effect of Low Molecular Weight Heparin.
    Zenerino C; Nuzzo AM; Giuffrida D; Biolcati M; Zicari A; Todros T; Rolfo A
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29149067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.